NYSE:CNCHealthcare
Centene (CNC) Valuation Check After Barclays Conference Selloff And ACA Marketplace Concerns
Centene (CNC) is back in focus after its Barclays Healthcare Conference appearance, where management discussed Affordable Care Act headwinds, enrollment declines, expiring premium subsidies, and lower 2026 revenue guidance, along with reaffirmed earnings targets.
See our latest analysis for Centene.
The conference commentary and reduced 2026 revenue outlook have come on top of already weak share price momentum, with a 7 day share price return of 20.29% decline and a 1 year total shareholder...